**Core Concept**
Empirical antitubercular therapy (ATT) is initiated in a patient with fever of unknown origin (FUO) when tuberculosis (TB) is suspected. The patient fails to respond to ATT, indicating a need to reassess the diagnosis or consider alternative causes.

**Why the Correct Answer is Right**
Continuation of ATT without a response may indicate that the diagnosis is incorrect, and the patient's symptoms are due to another underlying condition. The American Thoracic Society (ATS) and the Infectious Diseases Society of America (IDSA) recommend continuing ATT for at least 8-12 weeks before considering alternative diagnoses or switching to a different treatment regimen. This allows sufficient time for the anti-TB medications to take effect and for the patient to show a clinical response.

**Why Each Wrong Option is Incorrect**
**Option A:** 4 weeks is too short a duration to assess the effectiveness of ATT in a patient with FUO. Most patients will show some improvement within 4-6 weeks of treatment.
**Option B:** There is no standard duration for continuing ATT in patients with FUO who fail to respond. However, stopping ATT after 2 weeks is premature and may lead to treatment failure or relapse.
**Option C:** 6 months is an excessively long duration to continue ATT without a response. This may lead to unnecessary exposure to anti-TB medications, increasing the risk of side effects and drug resistance.

**Clinical Pearl / High-Yield Fact**
When a patient with FUO fails to respond to empirical ATT, it is essential to consider alternative diagnoses, such as brucellosis, endocarditis, or malignancy, and to perform further diagnostic testing to rule out these conditions.

**Correct Answer:** .